CELESTENE 4 mg/1 ml, solution for injection ampoule, 1 ml
Active ingredients: Betamethasone sodium phosphate, Betamethasone
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for injectionampoule, 1 mlendosinusale;intraarticulaire;intralésionnelle;intramusculaire;intraveineuse;périarticulaire;sous-conjonctivale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- CELESTENE 4 mg/1 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- endosinusale;intraarticulaire;intralésionnelle;intramusculaire;intraveineuse;périarticulaire;sous-conjonctivale
- Presentation description
- 1 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Dec 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62243639CIP73023675CIP133400930236758Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEsolution | 4,00 mg · une ampoule | FT |
| BÉTAMETHASONE (PHOSPHATE DE) ET DE DISODIUMsolution | 5,30 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.